| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Author index
|
|
|
2008
|
18 |
S1 |
p. S61-S65
5 p.
|
artikel
|
| 2 |
DL The ubiquitin-proteolytic system: from bench to bedside
|
Ciechanover, A.
|
|
2008
|
18 |
S1 |
p. S10-
1 p.
|
artikel
|
| 3 |
Editorial Board
|
|
|
2008
|
18 |
S1 |
p. i-
1 p.
|
artikel
|
| 4 |
OL Unravelling the mystery of neuroregulation of growth hormone secretion: the first fifty years
|
Reichlin, S.
|
|
2008
|
18 |
S1 |
p. S1-S2
2 p.
|
artikel
|
| 5 |
OR11,2 A central role of insulin-like growth factor-II in embryonic growth and the development of brain and pancreas in zebrafish
|
Netchine, I.
|
|
2008
|
18 |
S1 |
p. S22-
1 p.
|
artikel
|
| 6 |
OR9,3 Acid-labile subunit gene mutations: clinical, biochemical and molecular study in two unrelated families
|
Camacho-Hübner, C.
|
|
2008
|
18 |
S1 |
p. S18-
1 p.
|
artikel
|
| 7 |
OR11,4 A monoclonal antibody that targets a novel site on the beta3 subunit of the alphaVbeta3 integrin blocks lesion development in a porcine model of diabetes accelerated atherosclerosis
|
Maile, L.A.
|
|
2008
|
18 |
S1 |
p. S22-
1 p.
|
artikel
|
| 8 |
OR6,3 A novel IGF:IGFBP:vitronectin complex for treatments of wounds
|
Upton, Z.
|
|
2008
|
18 |
S1 |
p. S13-
1 p.
|
artikel
|
| 9 |
OR12,1 Bi-directional resistance pathways relevant to anti-IGF-1R targeted therapy: pathway to clinical development
|
Haluska, P.
|
|
2008
|
18 |
S1 |
p. S23-
1 p.
|
artikel
|
| 10 |
OR10,3 Bone mineral density in women with Turner syndrome treated with estrogen and growth hormone
|
Abe, K.
|
|
2008
|
18 |
S1 |
p. S20-S21
2 p.
|
artikel
|
| 11 |
OR7,3 Bone mineral density is a predictor of adiponectin and visfatin in patients with acromegaly
|
Sucunza, N.
|
|
2008
|
18 |
S1 |
p. S15-
1 p.
|
artikel
|
| 12 |
OR1,4 Cause-specific mortality in patients from the KIMS database and associations with IGF-I standard deviation scores (SDS)
|
Wilton, P.
|
|
2008
|
18 |
S1 |
p. S3-
1 p.
|
artikel
|
| 13 |
OR9,1 Chimeric vitronectin: IGF-I proteins enhance cell growth and provide a novel defined culture system for stem cells
|
Van Lonkhuyzen, D.
|
|
2008
|
18 |
S1 |
p. S18-
1 p.
|
artikel
|
| 14 |
OR1,5 Chronic growth hormone (GH) excess is associated with increased aldosterone in mice and humans
|
Bidlingmaier, M.
|
|
2008
|
18 |
S1 |
p. S4-
1 p.
|
artikel
|
| 15 |
OR7,1 Comparison of the effects of raloxifene and estrogen on growth hormone action in hypopituitary women
|
Birzniece, V.
|
|
2008
|
18 |
S1 |
p. S14-
1 p.
|
artikel
|
| 16 |
OR4,1 Defective Smad7 regulation contributes to excess IGFBP-3-dependent collagen I production in intestinal strictures in Crohn's disease
|
Flynn, R.S.
|
|
2008
|
18 |
S1 |
p. S8-
1 p.
|
artikel
|
| 17 |
OR5,4 Depot-specific proteomic analysis of adipose tissue from GHR-/- mice
|
Sackmann-Sala, L.
|
|
2008
|
18 |
S1 |
p. S11-
1 p.
|
artikel
|
| 18 |
OR5,5 d3-Growth hormone receptor polymorphism is not linked with modulation of IGF-I response to GH in acromegaly
|
Montefusco, L.
|
|
2008
|
18 |
S1 |
p. S12-
1 p.
|
artikel
|
| 19 |
OR3,4 Differential dose related GH- and IGF-insensitivity in children with idiopathic short stature and low serum IGF-I: comparison with growth hormone-deficient patients
|
Cohen, P.
|
|
2008
|
18 |
S1 |
p. S7-S8
2 p.
|
artikel
|
| 20 |
OR4,4 D413N mutation of the acid-labile subunit causes defects in secretion and ternary complex formation
|
Baxter, R.C.
|
|
2008
|
18 |
S1 |
p. S9-
1 p.
|
artikel
|
| 21 |
OR3,6 Effect of environment on growth: auxological and hormonal parameters in African and normal Italian children
|
Boschetti, M.
|
|
2008
|
18 |
S1 |
p. S8-
1 p.
|
artikel
|
| 22 |
OR9,2 Effects of a rowing-step test on saliva IGF-I levels in athletes
|
Antonelli, G.
|
|
2008
|
18 |
S1 |
p. S18-
1 p.
|
artikel
|
| 23 |
OR10,4 Effects of two years of growth hormone replacement therapy in adults with GHD in previously treated acromegaly
|
Norrman, L-L.
|
|
2008
|
18 |
S1 |
p. S21-
1 p.
|
artikel
|
| 24 |
OR3,1 Exon 3 deletion polymorphism of the growth hormone receptor (GHR) and GH response: a report of 97 cases (Manchester) and literature meta-analysis
|
Solomon, M.
|
|
2008
|
18 |
S1 |
p. S6-S7
2 p.
|
artikel
|
| 25 |
OR1,1 Factors determining inadequate hypoglycaemia during insulin tolerance testing after pituitary surgery
|
Lee, P.
|
|
2008
|
18 |
S1 |
p. S2-
1 p.
|
artikel
|
| 26 |
OR8,2 FAS mediates IGF-I-induced mitogenesis of breast cancer cells but not non-malignant breast epithelial cells
|
Jarrett, C.
|
|
2008
|
18 |
S1 |
p. S16-
1 p.
|
artikel
|
| 27 |
OR2,5 Fibronectin exposure reduces efficacy of chemotherapeutic agents on DU145 prostate cancer cells: an effect mediated via IGF-I and beta-1 integrin receptors
|
Perks, C.M.
|
|
2008
|
18 |
S1 |
p. S5-
1 p.
|
artikel
|
| 28 |
OR1,3 GH deficiency may impair cognitive and functional recovery after stroke
|
Bondanelli, M.
|
|
2008
|
18 |
S1 |
p. S3-
1 p.
|
artikel
|
| 29 |
OR4,3 Ghrelin reduces hepatic insulin action of IGFBP-1 production
|
Lewitt, M.
|
|
2008
|
18 |
S1 |
p. S9-
1 p.
|
artikel
|
| 30 |
OR5,1 Grb10-mediated recruitment of Eps15 to the IGF-IR regulates ligand-dependent receptor internalization and signalling
|
Monami, G.
|
|
2008
|
18 |
S1 |
p. S10-S11
2 p.
|
artikel
|
| 31 |
OR11,5 Hepatic insulin signals are enhanced in rats fed on low-protein diets, a model of IGF resistance
|
Toyoshima, Y.
|
|
2008
|
18 |
S1 |
p. S23-
1 p.
|
artikel
|
| 32 |
OR13,2 High dose and not low dose growth hormone treatment reverses type 2 diabetes in mice
|
List, E.
|
|
2008
|
18 |
S1 |
p. S25-
1 p.
|
artikel
|
| 33 |
OR11,3 IGFBP-3 as a unique promising therapeutic target for asthma: IGF-independent cross-talk and interference with NF-kB signalling
|
Oh, Y.
|
|
2008
|
18 |
S1 |
p. S22-
1 p.
|
artikel
|
| 34 |
OR12,5 IGFBP-5 induces extracellular matrix production via Egr-1 and MAPK-dependent pathways
|
Feghali-Bostwick, C.
|
|
2008
|
18 |
S1 |
p. S24-
1 p.
|
artikel
|
| 35 |
OR4,2 IGFBP-1 in women and men during the development of type 2 diabetes
|
Lewitt, M.S.
|
|
2008
|
18 |
S1 |
p. S9-
1 p.
|
artikel
|
| 36 |
OR13,5 IGFBP-2 null mice develop obesity and insulin resistance with aging
|
DeMambro, V.E.
|
|
2008
|
18 |
S1 |
p. S26-
1 p.
|
artikel
|
| 37 |
OR13,4 IGF-I is an important niche factor that determines placental mesenchymal stem cell fate via specific cell-signaling mechanisms
|
Iosef, C.
|
|
2008
|
18 |
S1 |
p. S25-S26
2 p.
|
artikel
|
| 38 |
OR8,3 IGF-IR and IR quantification and signaling in murine primary mammary epithelial cells
|
Rowzee, A.M.
|
|
2008
|
18 |
S1 |
p. S16-
1 p.
|
artikel
|
| 39 |
OR12,4 IGF-IR-dependent activation of Survivin is required in T-antigen-mediated stimulation of proliferation and survival of neural progenitors
|
Gualco, E.
|
|
2008
|
18 |
S1 |
p. S24-
1 p.
|
artikel
|
| 40 |
OR9,4 IGF-1R ubiquitination: from signaling to receptor degradation
|
Girnita, L.
|
|
2008
|
18 |
S1 |
p. S19-
1 p.
|
artikel
|
| 41 |
OR12,3 Insulin-like growth factor I protects cells from ER stress-induced apoptosis via enhancement of the adaptive capacity of endoplasmic reticulum
|
Novosyadlyy, R.
|
|
2008
|
18 |
S1 |
p. S24-
1 p.
|
artikel
|
| 42 |
OR5,2 Insulin receptor substrate (IRS)-1 around endosomes, sorted by adaptor protein (AP)-1, is essential for IGF-I-induced DNA synthesis in L6 myoblasts
|
Matsuo, M.
|
|
2008
|
18 |
S1 |
p. S11-
1 p.
|
artikel
|
| 43 |
OR9,5 Insulin receptor substrates (IRSs) form a high-molecular-mass complex containing RNAs as well as proteins that function in RNA processing
|
Sone, M.
|
|
2008
|
18 |
S1 |
p. S19-
1 p.
|
artikel
|
| 44 |
OR2,6 Interrelationship between somatostatin/dopamine pathways and growth factors in non-small lung cancer cells
|
Arvigo, M.
|
|
2008
|
18 |
S1 |
p. S5-S6
2 p.
|
artikel
|
| 45 |
OR6,5 Intramyocellular lipids during exercise: comparison of growth hormone deficient patients and endurance trained athletes
|
Egger, A.
|
|
2008
|
18 |
S1 |
p. S13-
1 p.
|
artikel
|
| 46 |
OR11,1 Liver-derived circulating IGF-I is sufficient to restore linear growth in an IGF-I null mouse
|
Wu, Y.
|
|
2008
|
18 |
S1 |
p. S21-
1 p.
|
artikel
|
| 47 |
OR11,6 Liver-derived IGF-I regulates life span in mice
|
Svensson, J.
|
|
2008
|
18 |
S1 |
p. S23-
1 p.
|
artikel
|
| 48 |
OR6,4 Marked reductions in bioactive IGF-I during hemodialysis
|
Ivarsen, P.
|
|
2008
|
18 |
S1 |
p. S13-
1 p.
|
artikel
|
| 49 |
OR5,3 Nedd4 interacts with insulin receptor substrate (IRS)-1 and IRS-2 leading to enhancement of IGF signals through the PI 3-kinase pathway in a different manner
|
Fukushima, T.
|
|
2008
|
18 |
S1 |
p. S11-
1 p.
|
artikel
|
| 50 |
OR4,6 New insights into metabolism from IGFBP-3 knockout mice
|
Yamada, P.M.
|
|
2008
|
18 |
S1 |
p. S10-
1 p.
|
artikel
|
| 51 |
OR3,2 Optimization of first year height velocity in short children born SGA by individual GH dose adjustment
|
Land, C.
|
|
2008
|
18 |
S1 |
p. S7-
1 p.
|
artikel
|
| 52 |
OR10,5 Outcome of quality of life and body composition after discontinuation of growth hormone in adult hypopituitary patients — a randomised placebo-controlled trial
|
Filipsson, H.
|
|
2008
|
18 |
S1 |
p. S21-
1 p.
|
artikel
|
| 53 |
OR8,4 Overexpression of IRS-1 suppresses initiation of myogenesis through exclusion of Foxo1 from the nucleus in the PI 3-kinase-dependent mechanism
|
Yamauchi, Y.
|
|
2008
|
18 |
S1 |
p. S16-S17
2 p.
|
artikel
|
| 54 |
OR12,2 p125, a novel PI 3-kinase-associated protein (PITKAP) plays an essential role in cAMP-dependent potentiation of IGF bioactivities in a thyroid cell line
|
Yamanaka, D.
|
|
2008
|
18 |
S1 |
p. S23-S24
2 p.
|
artikel
|
| 55 |
OR7,2 Pharmacokinetic and pharmacodynamic characterisation of NNC 126-0083, a long-acting growth hormone derivative
|
Thygesen, P.
|
|
2008
|
18 |
S1 |
p. S14-S15
2 p.
|
artikel
|
| 56 |
OR3,3 Polymorphisms associated with changes in serum IGF-I after GH therapy in children with GHD or Turner syndrome
|
Clayton, P.
|
|
2008
|
18 |
S1 |
p. S7-
1 p.
|
artikel
|
| 57 |
OR2,2 Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF-IGFBP axis
|
Koyama, S.
|
|
2008
|
18 |
S1 |
p. S4-
1 p.
|
artikel
|
| 58 |
OR2,3 Pro-survival growth hormone signaling is activated in response to IGF knockdown in prostate cancer
|
Cobb, L.
|
|
2008
|
18 |
S1 |
p. S4-S5
2 p.
|
artikel
|
| 59 |
OR4,5 Proteolysis of IGFBP-5 in pregnancy
|
Firth, S.M.
|
|
2008
|
18 |
S1 |
p. S9-S10
2 p.
|
artikel
|
| 60 |
OR13,6 Regulation of IGF-I receptor signaling and the CUL7 ubiquitin ligase by the Parkinson's Disease protein GIGYF2
|
Tsiaras, W.G.
|
|
2008
|
18 |
S1 |
p. S26-
1 p.
|
artikel
|
| 61 |
OR1,2 Risk factors for pituitary dysfunction following moderate or severe traumatic brain injury (TBI)
|
Prodam, F.
|
|
2008
|
18 |
S1 |
p. S3-
1 p.
|
artikel
|
| 62 |
OR8,1 Role of PTEN in IGF-I signalling on astrocytes
|
Fernández, S.
|
|
2008
|
18 |
S1 |
p. S16-
1 p.
|
artikel
|
| 63 |
OR6,2 Short stature caused by a novel heterozygous mutation in the IGF-I gene
|
van Duyvenvoorde, H.A.
|
|
2008
|
18 |
S1 |
p. S12-
1 p.
|
artikel
|
| 64 |
OR2,1 Starvation-dependent differential stress resistance protects normal but not cancer cells against high dose chemotherapy
|
Longo, V.
|
|
2008
|
18 |
S1 |
p. S4-
1 p.
|
artikel
|
| 65 |
OR6,1 Telomere length is associated with exceptional longevity and is modulated by the IGF system
|
Atzmon, G.
|
|
2008
|
18 |
S1 |
p. S12-
1 p.
|
artikel
|
| 66 |
OR10,1 Ten-year GH replacement in elderly GH deficient adults increases bone mineral density
|
Svensson, J.
|
|
2008
|
18 |
S1 |
p. S20-
1 p.
|
artikel
|
| 67 |
OR2,4 The development of multi-dimensional models of serum IGF-I, -II, IGFBP-2 and -3 using artificial neural networks as “composite biomarkers” to predict colorectal cancer
|
Renehan, A.
|
|
2008
|
18 |
S1 |
p. S5-
1 p.
|
artikel
|
| 68 |
OR7,5 The diagnosis of growth hormone deficiency after adult height achievement
|
Secco, A.
|
|
2008
|
18 |
S1 |
p. S15-S16
2 p.
|
artikel
|
| 69 |
OR13,1 The impact of fasting on growth hormone signaling and action in muscle and fat tissue in human subjects
|
Moller, L.
|
|
2008
|
18 |
S1 |
p. S25-
1 p.
|
artikel
|
| 70 |
OR8,5 The molecular mechanism underlying enhanced breast cell migration stimulated by IGF-I:IGFBP-5:VN complexes
|
Hollier, B.
|
|
2008
|
18 |
S1 |
p. S17-
1 p.
|
artikel
|
| 71 |
OR13,3 The role of autocrine human growth hormone in radioresistance of mammary carcinoma cells
|
Bougen, N.
|
|
2008
|
18 |
S1 |
p. S25-
1 p.
|
artikel
|
| 72 |
OR3,5 The role of IGF1 system in mediating estrogen effects on growth and epiphyseal proliferation in males: insight from peripubertal aromatase deficiency model
|
Werther, G.
|
|
2008
|
18 |
S1 |
p. S8-
1 p.
|
artikel
|
| 73 |
OR7,4 The somatotroph response to acylated ghrelin is refractory to the negative GH auto-feedback, but is sensitive to negative IGF-I feedback in man
|
Riganti, F.
|
|
2008
|
18 |
S1 |
p. S15-
1 p.
|
artikel
|
| 74 |
OR10,2 Three years safety and efficacy of a novel once-a-week sustained release rhGH (LB03002) in treatment-naive prepubertal children with GHD*
|
Peter, F.
|
|
2008
|
18 |
S1 |
p. S20-
1 p.
|
artikel
|
| 75 |
P-33 ACTH releasing activity of GH releasing peptide-2 in patients with hypothalamo-pituitary diseases
|
Yamakado, Y.
|
|
2008
|
18 |
S1 |
p. S37-
1 p.
|
artikel
|
| 76 |
P-11 Activation of cAMP responsive element binding protein 1 (CREB1) by stimulation of the Src/ERK pathway is a common mechanism underlying IGF-I receptor upregulation by androgens and estrogens in prostate cancer cells
|
Genua, M.
|
|
2008
|
18 |
S1 |
p. S30-
1 p.
|
artikel
|
| 77 |
P-27 Adapting and validating Eastern European language versions of the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA)
|
McKenna, S.
|
|
2008
|
18 |
S1 |
p. S35-
1 p.
|
artikel
|
| 78 |
P-80 Analysis of cellular effects of epigenetic mutations at the IGF2/H19 locus in Silver–Russell syndrome
|
Kannenberg, K.
|
|
2008
|
18 |
S1 |
p. S50-
1 p.
|
artikel
|
| 79 |
P-66 An observational, controlled study to compare the prevalence and severity of cardiovascular disease in childhood onset vs. adulthood onset growth hormone deficiency
|
Colao, A.
|
|
2008
|
18 |
S1 |
p. S46-
1 p.
|
artikel
|
| 80 |
P-48 A PK/PD model for characterisation of NNC 126-0083, a long-acting growth hormone derivative with respect to efficacy, time of duration and dose selection
|
Thygesen, P.
|
|
2008
|
18 |
S1 |
p. S41-
1 p.
|
artikel
|
| 81 |
P-81 A possible role of IGF system in the abnormal bone formation in achondroplastic subjects
|
Palermo, C.
|
|
2008
|
18 |
S1 |
p. S50-S51
2 p.
|
artikel
|
| 82 |
P-45 A potential role for growth hormone in injury-induced neurogenesis in the immature rat brain
|
Christophidis, L.
|
|
2008
|
18 |
S1 |
p. S40-
1 p.
|
artikel
|
| 83 |
P-26 Body mass index (BMI) and waist circumference in growth hormone (GH)-untreated adult-onset hypopituitarism in relation to age-dependent general population normative data
|
Koltowska-Haggstrom, M.
|
|
2008
|
18 |
S1 |
p. S34-S35
2 p.
|
artikel
|
| 84 |
P-23 Bone mineral density and alkaline phosphatase in growth hormone-treated GH-deficient young adults
|
Conway, G.S.
|
|
2008
|
18 |
S1 |
p. S33-S34
2 p.
|
artikel
|
| 85 |
P-95 Carnosine up-regulates liver IGF-I and decreases tissue cholesterol
|
Santos, E.
|
|
2008
|
18 |
S1 |
p. S55-
1 p.
|
artikel
|
| 86 |
P-41 Comparison of growth promoting effect of rhGH and rh IGF-I in patients with isolated GHD type IA
|
Horikawa, R.
|
|
2008
|
18 |
S1 |
p. S39-
1 p.
|
artikel
|
| 87 |
P-74 Congenital IGF-I deficiency effects on dental morphology and histology in patients with Laron syndrome
|
Wright, T.
|
|
2008
|
18 |
S1 |
p. S49-
1 p.
|
artikel
|
| 88 |
P-49 Control of IGF-1 and headache during medical treatment in acromegaly
|
Sanno, N.
|
|
2008
|
18 |
S1 |
p. S41-
1 p.
|
artikel
|
| 89 |
P-76 Correlation between N-terminal pro-B-type natiuretic peptide and left ventricular mass in acromegaly
|
Romanello, G.
|
|
2008
|
18 |
S1 |
p. S49-
1 p.
|
artikel
|
| 90 |
P-105 CXCR4 expression in lymphocytes of IGF-I deficient mice infected with an intracellular pathogen
|
Cuervo-Escobar, S.
|
|
2008
|
18 |
S1 |
p. S58-
1 p.
|
artikel
|
| 91 |
P-64 Decreased p44/42 MAPK phosphorylation in gender- or hormone-related but not during age-related adrenal gland growth in mice
|
Bielohuby, M.
|
|
2008
|
18 |
S1 |
p. S46-
1 p.
|
artikel
|
| 92 |
P-61 Differential signaling by insulin and insulin-like growth factors upon binding to insulin receptor isoform A
|
Sacco, A.
|
|
2008
|
18 |
S1 |
p. S45-
1 p.
|
artikel
|
| 93 |
P-40 Economic evaluation of somatropin (Norditropin®) for the treatment of short children born SGA in Sweden
|
Twena, N.
|
|
2008
|
18 |
S1 |
p. S39-
1 p.
|
artikel
|
| 94 |
P-37 Effect of GH therapy on coronary flow reserve, diastolic filling and cardiovascular risk factors in adult GHD
|
Boschetti, M.
|
|
2008
|
18 |
S1 |
p. S38-
1 p.
|
artikel
|
| 95 |
P-07 Effects of GHR stimulation and blockade on growth of prostate cancer cell lines
|
Strawbridge, R.J.
|
|
2008
|
18 |
S1 |
p. S28-S29
2 p.
|
artikel
|
| 96 |
P-78 Estimates of the bioactivity of IGF-II in serum from healthy subjects, obese subjects and obese type 2 diabetic patients
|
Frystyk, J.
|
|
2008
|
18 |
S1 |
p. S50-
1 p.
|
artikel
|
| 97 |
P-89 Function and regulation of insulin-like growth factor binding protein-2 and -3 in ovarian cancer cell models
|
Schuett, B.S.
|
|
2008
|
18 |
S1 |
p. S53-
1 p.
|
artikel
|
| 98 |
P-44 Gender related IGF-I changes after two years of growth hormone (GH) treatment in GH deficient (GHD) children and adults. Data from the NordiNet® International Outcome Study (IOS)
|
Sävendahl, L.
|
|
2008
|
18 |
S1 |
p. S40-
1 p.
|
artikel
|
| 99 |
P-73 GF-I treatment of patients with Laron syndrome suppresses thrombopoietin levels but does not affect erythropoietin
|
Shevah, O.
|
|
2008
|
18 |
S1 |
p. S48-
1 p.
|
artikel
|
| 100 |
P-39 GH Deficiency following traumatic brain injury (TBI) as a cause of female infertility
|
Giampietro, A.
|
|
2008
|
18 |
S1 |
p. S38-
1 p.
|
artikel
|
| 101 |
P-59 GH fragment measurements: a new laboratory tool for GH state investigation in humans
|
De Palo, E.F.
|
|
2008
|
18 |
S1 |
p. S44-
1 p.
|
artikel
|
| 102 |
P-30 Growth hormone deficiency and acromegaly have comparable effects on bone mass and osteoporotic fracture risk in adult women
|
Mazziotti, G.
|
|
2008
|
18 |
S1 |
p. S36-
1 p.
|
artikel
|
| 103 |
P-31 Growth hormone does not affect cardiac function in men with the metabolic syndrome and obstructive sleep apnea
|
Franco, C.
|
|
2008
|
18 |
S1 |
p. S36-
1 p.
|
artikel
|
| 104 |
P-02 Growth hormone induces chemoresistance in breast cancer cells
|
Zatelli, M.C.
|
|
2008
|
18 |
S1 |
p. S27-
1 p.
|
artikel
|
| 105 |
P-19 Growth hormone treatment increases obstructive sleep apnea index and neck soft tissue mass in abdominally obese men
|
Koranyi, J.
|
|
2008
|
18 |
S1 |
p. S32-
1 p.
|
artikel
|
| 106 |
P-20 Growth hormone treatment in patients on hemodialysis is associated with an increase in serum mannose-binding lectin levels
|
Hansen, T.K.
|
|
2008
|
18 |
S1 |
p. S33-
1 p.
|
artikel
|
| 107 |
P-46 Growth hormone treatment in postmenopausal women, effects on aerobic working capacity and the heart
|
Berggren, A.
|
|
2008
|
18 |
S1 |
p. S40-S41
2 p.
|
artikel
|
| 108 |
P-94 Growth hormone treatment prevents loss of lean mass after bariatric surgery in morbidly obese patients. Results of a pilot, open, prospective, randomized, controlled study
|
Savastano, S.
|
|
2008
|
18 |
S1 |
p. S54-
1 p.
|
artikel
|
| 109 |
P-55 Hearing loss in patients with Laron syndrome (primary growth hormone insensitivity) is reversed by early IGF-I replacement therapy
|
Attias, J.
|
|
2008
|
18 |
S1 |
p. S43-
1 p.
|
artikel
|
| 110 |
P-01 HER receptor signaling confers resistance to the insulin-like growth factor 1 receptor inhibitor, BMS-536924
|
Haluska, P.
|
|
2008
|
18 |
S1 |
p. S27-
1 p.
|
artikel
|
| 111 |
P-17 Heterogeneous clinical presentation in patients with yet-unreported type 1 IGF receptor molecular defects
|
Azzi, S.
|
|
2008
|
18 |
S1 |
p. S32-
1 p.
|
artikel
|
| 112 |
P-65 High fat/low carbohydrate diets: effects on serum IGF-I and bone growth in rats
|
Bielohuby, M.
|
|
2008
|
18 |
S1 |
p. S46-
1 p.
|
artikel
|
| 113 |
P-86 High molecular mass forms of IGFBP-1 associated with placental cell membranes
|
Masnikosa, R.
|
|
2008
|
18 |
S1 |
p. S52-
1 p.
|
artikel
|
| 114 |
P-52 High risk of hypopituitarism in patients who recovered from hemorrhagic fever with renal syndrome
|
Stojanovic, M.
|
|
2008
|
18 |
S1 |
p. S42-
1 p.
|
artikel
|
| 115 |
P-51 24-h mean acyl-ghrelin levels are decreased in older adults
|
Nass, R.
|
|
2008
|
18 |
S1 |
p. S42-
1 p.
|
artikel
|
| 116 |
P-84 Human microvascular endothelial cells are sensitive to IGF-I but insensitive to insulin
|
Johansson, G.S.
|
|
2008
|
18 |
S1 |
p. S51-
1 p.
|
artikel
|
| 117 |
P-91 IGFBP-3 in cellular senescence; molecular and clinical implications
|
Garza, A.E.
|
|
2008
|
18 |
S1 |
p. S53-S54
2 p.
|
artikel
|
| 118 |
P-43 IGF-I and hemoglobin during GH treatment in children born SGA
|
Rapaport, R.
|
|
2008
|
18 |
S1 |
p. S39-S40
2 p.
|
artikel
|
| 119 |
P-08 IGF-I, IGFBP-3 and cancer risk: poor performance on discrimination analysis as an explanation of inconsistencies between risk-association studies
|
Renehan, A.G.
|
|
2008
|
18 |
S1 |
p. S29-
1 p.
|
artikel
|
| 120 |
P-87 IGF-I:IGFBP-3 molar ratio and disease risk: statistical considerations and level of agreement with free IGF-I
|
Renehan, A.G.
|
|
2008
|
18 |
S1 |
p. S52-
1 p.
|
artikel
|
| 121 |
P-98 IGF II immunohistochemistry in breast cancer (BC). Relationship with several predictive parameters in breast malignancy
|
Giustarini, E.
|
|
2008
|
18 |
S1 |
p. S56-
1 p.
|
artikel
|
| 122 |
P-71 IGF-I recovers mitochondrial function in critically ill patients
|
Horikawa, R.
|
|
2008
|
18 |
S1 |
p. S48-
1 p.
|
artikel
|
| 123 |
P-106 IGF-I regulates protein oxidation by modulating proteasome activity
|
Torres, C.
|
|
2008
|
18 |
S1 |
p. S58-
1 p.
|
artikel
|
| 124 |
P-15 IGF pathway in neuroendocrine cancer: expression and prognostic role
|
Cascella, T.
|
|
2008
|
18 |
S1 |
p. S31-
1 p.
|
artikel
|
| 125 |
P-12 IGF-1R as therapeutic target in melanoma
|
Girnita, A.
|
|
2008
|
18 |
S1 |
p. S30-
1 p.
|
artikel
|
| 126 |
P-72 IGF systems at diagnosis in pubertal adolescent with type 1 diabetes mellitus
|
Chisalita, S.I.
|
|
2008
|
18 |
S1 |
p. S48-
1 p.
|
artikel
|
| 127 |
P-67 IGF Targeting of the IGF-IR as a potential therapeutic strategy in endometrial cancer
|
Attias, Z.
|
|
2008
|
18 |
S1 |
p. S47-
1 p.
|
artikel
|
| 128 |
P-57 Increased prevalence of acromegaly in an industrialized area of north-east of Sicily: a case-control study
|
Ferraù, F.
|
|
2008
|
18 |
S1 |
p. S43-S44
2 p.
|
artikel
|
| 129 |
P-104 Insulin and IGF-I receptors play a role in invasion of human trophoblast through MMP-9 activation
|
Vallejo, A.F.
|
|
2008
|
18 |
S1 |
p. S58-
1 p.
|
artikel
|
| 130 |
P-16 Insulin/IGF system in human pituitary tumour: clinical and patho-biological insight
|
Cascella, T.
|
|
2008
|
18 |
S1 |
p. S31-
1 p.
|
artikel
|
| 131 |
P-79 Insulin like growth factor 1 in prostate cancer
|
Pidaniĉová, A.
|
|
2008
|
18 |
S1 |
p. S50-
1 p.
|
artikel
|
| 132 |
P-107 Insulin-like growth factor-I prevents oxidative stress-induced apoptosis through PI3K p110a in myoblasts
|
Matheny, W.
|
|
2008
|
18 |
S1 |
p. S58-S59
2 p.
|
artikel
|
| 133 |
P-09 Interactions between androgen receptor and BRCA1 in regulation of IGF-I receptor gene expression in prostate cancer cells
|
Schayek, H.
|
|
2008
|
18 |
S1 |
p. S29-
1 p.
|
artikel
|
| 134 |
P-54 Intravascular large B-cell lymphoma as a cause of reversible hypopituitarism
|
Pekic, S.
|
|
2008
|
18 |
S1 |
p. S43-
1 p.
|
artikel
|
| 135 |
P-85 Is there a role for vitamin A on the regulation of IGF-I in children?
|
Martinelli Jr., C.E.
|
|
2008
|
18 |
S1 |
p. S52-
1 p.
|
artikel
|
| 136 |
PL10 Everything in moderation: metabolic effects of GH
|
Jorgensen, J.O.
|
|
2008
|
18 |
S1 |
p. S19-S20
2 p.
|
artikel
|
| 137 |
PL7 GH signalling
|
Schwartz, J.
|
|
2008
|
18 |
S1 |
p. S17-
1 p.
|
artikel
|
| 138 |
PL3 How does the GH cell network function to build-up highly ordered GH pulses?
|
Mollard, P.
|
|
2008
|
18 |
S1 |
p. S6-
1 p.
|
artikel
|
| 139 |
PL2 IGF-I treatment across the lifespan
|
Camacho-Hübner, C.
|
|
2008
|
18 |
S1 |
p. S2-
1 p.
|
artikel
|
| 140 |
PL4 Imaging insights into hypopituitarism
|
Maghnie, M.
|
|
2008
|
18 |
S1 |
p. S6-
1 p.
|
artikel
|
| 141 |
PL5 Insulin receptor isoforms in physiology and disease: impact on IGF system
|
Belfiore, A.
|
|
2008
|
18 |
S1 |
p. S13-S14
2 p.
|
artikel
|
| 142 |
PL8 Long-range chromosomal interactions in the regulation of IGF2 imprinting
|
Hoffman, A.
|
|
2008
|
18 |
S1 |
p. S17-S18
2 p.
|
artikel
|
| 143 |
PL1 New GH-related molecules with therapeutic potential
|
Ross, R.
|
|
2008
|
18 |
S1 |
p. S2-
1 p.
|
artikel
|
| 144 |
PL9 Regulation of pancreatic endocrine function by IGF and insulin signalling
|
Accili, D.
|
|
2008
|
18 |
S1 |
p. S19-
1 p.
|
artikel
|
| 145 |
PL6 The role of the IGF-IR in cancer: initiation and progression or therapeutic target?
|
Plymate, S.
|
|
2008
|
18 |
S1 |
p. S14-
1 p.
|
artikel
|
| 146 |
P-32 Metabolic complications in patients with adult growth hormone deficiency
|
Kurimoto, M.
|
|
2008
|
18 |
S1 |
p. S36-
1 p.
|
artikel
|
| 147 |
P-42 Metabolic profile of patients with idiopatic short stature (ISS) according to GH and IGF-I status
|
Martinelli, C.
|
|
2008
|
18 |
S1 |
p. S39-
1 p.
|
artikel
|
| 148 |
P-28 Metabolic status at baseline and after 3 years of GH treatment in patients with Cushing's disease and non-functioning adenomas: a hypopituitary control and complications study analysis
|
Webb, S.
|
|
2008
|
18 |
S1 |
p. S35-
1 p.
|
artikel
|
| 149 |
P-10 Mitogenic activity and signaling pathways elicited by long-acting insulin analogues Glargine and Detemir in colon cancer derived cell lines
|
Weinstein, D.
|
|
2008
|
18 |
S1 |
p. S29-S30
2 p.
|
artikel
|
| 150 |
P-63 Molecular mechanisms underlying the anti-inflammatory action of IGF-I in astrocytes
|
Fernández, A.M.
|
|
2008
|
18 |
S1 |
p. S45-
1 p.
|
artikel
|
| 151 |
P-75 Muscle expression of MGF, IGF-IEa and myostatin in intact and hypophysectomized rats: effects of rhGH testosterone alone or combined
|
Bonomo, S.M.
|
|
2008
|
18 |
S1 |
p. S49-
1 p.
|
artikel
|
| 152 |
P-101 Neuronal activity regulates serum IGF-I input to the brain
|
Nishijima, T.
|
|
2008
|
18 |
S1 |
p. S57-
1 p.
|
artikel
|
| 153 |
P-03 Obestatin and ghrelin function in ovarian cancer cell lines,
|
Walpole, C.
|
|
2008
|
18 |
S1 |
p. S27-
1 p.
|
artikel
|
| 154 |
P-69 Patients with liver cirrhosis have higher levels of bioactive IGF-I in ascites than in serum
|
Jeyaratnaganthan, N.
|
|
2008
|
18 |
S1 |
p. S47-
1 p.
|
artikel
|
| 155 |
P-70 Peripheral sensory neuropathy in type 2 diabetes is associated with increased IGFBP-1
|
Kärvestedt, L.
|
|
2008
|
18 |
S1 |
p. S47-S48
2 p.
|
artikel
|
| 156 |
P-58 Pharmacokinetics and pharmacodynamics of a single injection of a pegylated long-acting recombinant growth hormone
|
Bysted, B.
|
|
2008
|
18 |
S1 |
p. S44-
1 p.
|
artikel
|
| 157 |
P-56 Pituitary function in young ischemic stroke patient: preliminary data
|
Di Somma, C.
|
|
2008
|
18 |
S1 |
p. S43-
1 p.
|
artikel
|
| 158 |
P-97 Predictive value of insulin like growth factor II (IGF-II) mRNA expression in breast cancer (BC)
|
Fiore, E.
|
|
2008
|
18 |
S1 |
p. S55-
1 p.
|
artikel
|
| 159 |
P-35 Preference of growth hormone provocative test in diagnosing GH deficiency in clinical practice — data from Japanese HypoCCS study
|
Shimatsu, A.
|
|
2008
|
18 |
S1 |
p. S37-
1 p.
|
artikel
|
| 160 |
P-109 Production of mouse growth hormone antagonist (G118K)
|
Gosney, E.
|
|
2008
|
18 |
S1 |
p. S59-
1 p.
|
artikel
|
| 161 |
P-100 Promoter haplotype in the insulin-like growth factor-binding protein-3 gene: correlation with serum levels, growth and response to growth hormone treatment in short children born small for gestational age
|
van der Kaay, D.
|
|
2008
|
18 |
S1 |
p. S56-S57
2 p.
|
artikel
|
| 162 |
P-99 Promoter polymorphism in the insulin-like growth factor-binding protein-1 gene: correlation with serum IGFBP-1 levels and insulin levels in short children born small for gestational age
|
van der Kaay, D.
|
|
2008
|
18 |
S1 |
p. S56-
1 p.
|
artikel
|
| 163 |
P-38 Prospective comparison of the Glucagon Stimulation Test (GST) with the Insulin Tolerance Test (ITT) in patients following pituitary surgery
|
Berg, C.
|
|
2008
|
18 |
S1 |
p. S38-
1 p.
|
artikel
|
| 164 |
P-62 Regulation of suppressor of cytokine signalling-2 gene expression in liver and kidney by estradiol, growth hormone and thyroid hormone interaction
|
Santana-Farré, R.
|
|
2008
|
18 |
S1 |
p. S45-
1 p.
|
artikel
|
| 165 |
P-21 Relationship between IGF-I levels and peripheral nerve enlargement in acromegaly
|
Resmini, E.
|
|
2008
|
18 |
S1 |
p. S33-
1 p.
|
artikel
|
| 166 |
P-77 Relationships between serum insulin-like growth factor-I levels, blood pressure and glucose tolerance: an observational, exploratory study in 404 subjects
|
Colao, A.
|
|
2008
|
18 |
S1 |
p. S49-S50
2 p.
|
artikel
|
| 167 |
Program at a glance
|
|
|
2008
|
18 |
S1 |
p. vi-
1 p.
|
artikel
|
| 168 |
P-88 Role of oxidative stress on the regulation of IGFBP-1 mRNA in protein-deprived rat liver
|
Takenaka, A.
|
|
2008
|
18 |
S1 |
p. S52-S53
2 p.
|
artikel
|
| 169 |
P-18 Russell-Silver Syndrome: clinical scoring system and molecular investigations on a large series of patients
|
Netchine, I.
|
|
2008
|
18 |
S1 |
p. S32-
1 p.
|
artikel
|
| 170 |
P-103 Serum levels of IGF-1, IGFBP-1, CoQ10 and Vitamin E in four female populations from Poland, Serbia, and Sweden
|
Tekle, M.
|
|
2008
|
18 |
S1 |
p. S57-
1 p.
|
artikel
|
| 171 |
P-04 Short-interfering RNA for targeting IGFs in tumour cells
|
Durfort, T.
|
|
2008
|
18 |
S1 |
p. S28-
1 p.
|
artikel
|
| 172 |
P-60 Signaling differences in the A and B isoforms of the insulin receptor in 32D cells stimulated by either insulin or IGF-II in the presence of IRS-3
|
Cassarino, M.F.
|
|
2008
|
18 |
S1 |
p. S44-S45
2 p.
|
artikel
|
| 173 |
P-05 Specific targeting of IGF-I and IGF-IR genes by antigene nucleic acids
|
Oussedik, K.
|
|
2008
|
18 |
S1 |
p. S28-
1 p.
|
artikel
|
| 174 |
P-83 Study of two IGF-1R gene expression variants
|
Steunou, V.
|
|
2008
|
18 |
S1 |
p. S51-
1 p.
|
artikel
|
| 175 |
P-50 Sweat secretion in obese subjects with hyposomatotropism
|
Rasmussen, M. Højby
|
|
2008
|
18 |
S1 |
p. S41-S42
2 p.
|
artikel
|
| 176 |
P-22 Ten-year growth hormone (GH) replacement normalizes muscle strength in GH deficient adults
|
Götherström, G.
|
|
2008
|
18 |
S1 |
p. S33-
1 p.
|
artikel
|
| 177 |
P-34 The effect of GH-IGF-I axis on renin-angiotensin system (RAS) and cardiac structure and function in patients with acromegaly
|
Tanaka, S.
|
|
2008
|
18 |
S1 |
p. S37-
1 p.
|
artikel
|
| 178 |
P-47 The effect of growth hormone (GH) and insulin-like growth factor I (IGF-I) on expression of 11β-hydroxysteroid dehydrogenase type1 (HSD1) mRNA in 3T3-L1 adipocytes
|
Ishikawa, Y.
|
|
2008
|
18 |
S1 |
p. S41-
1 p.
|
artikel
|
| 179 |
P-68 The GH-IGF axis in glycogen storage disease type 1 (GSD): Evidence of different growth patterns and IGF levels in patients with GSD1 A and GSD1 B
|
Pivonello, R.
|
|
2008
|
18 |
S1 |
p. S47-
1 p.
|
artikel
|
| 180 |
P-14 The IGF-1 receptor inhibitor PPP induces increased cellular uptake of glucose. Interactions between IGF-1R and insulin receptor?
|
Vasilcanu, D.
|
|
2008
|
18 |
S1 |
p. S31-
1 p.
|
artikel
|
| 181 |
P-90 The IGF system in atherosclerosis. Effect of IGFBP-1 on rat SMC proliferation in different glucose conditions
|
Wang, J.
|
|
2008
|
18 |
S1 |
p. S53-
1 p.
|
artikel
|
| 182 |
P-92 The influence of glucose intake on the relative abundance of IGFBP-1 phosphoforms in the circulation
|
Nedic, O.
|
|
2008
|
18 |
S1 |
p. S54-
1 p.
|
artikel
|
| 183 |
P-25 The influences of the standardization of GH assay on the criteria for evaluating the effect of treatment of acromegaly in Japan
|
Fukuda, I.
|
|
2008
|
18 |
S1 |
p. S34-
1 p.
|
artikel
|
| 184 |
P-96 The new IGF-I-responsive protein EVA promotes survival and migration signalling through regulation of endosomal pH by the V-ATPase
|
O'Callaghan, K.M.
|
|
2008
|
18 |
S1 |
p. S55-
1 p.
|
artikel
|
| 185 |
P-82 The physiological variability of insulin growth factor I and procollagen type III in amateur and elite athletes: implications in detecting growth hormone abuse in sports
|
Erotokritou, I.
|
|
2008
|
18 |
S1 |
p. S51-
1 p.
|
artikel
|
| 186 |
P-24 The Power of the Mind: an evaluation of the placebo effect in a study of GH on physical performance
|
Meinhardt, U.
|
|
2008
|
18 |
S1 |
p. S34-
1 p.
|
artikel
|
| 187 |
P-53 The pre-treatment with acylated ghrelin abolishes the GH response to GHRH and inhibits that to GHRH+ARGININE and ghrelin itself
|
Olivetti, I.
|
|
2008
|
18 |
S1 |
p. S42-S43
2 p.
|
artikel
|
| 188 |
P-102 The relationship between central adrenal insufficiency and sleep related breathing disorders in children with Prader-Willi syndrome
|
de Lind van Wijngaarden, R.
|
|
2008
|
18 |
S1 |
p. S57-
1 p.
|
artikel
|
| 189 |
P-29 The response of plasma ACTH and AVP to growth hormone-releasing peptide-2 (GHRP-2) in healthy adults
|
Tanimoto, K.
|
|
2008
|
18 |
S1 |
p. S35-S36
2 p.
|
artikel
|
| 190 |
P-108 The role of PPARgamma and IGFBP-3 in regulating breast cancer
|
Pon, C.
|
|
2008
|
18 |
S1 |
p. S59-
1 p.
|
artikel
|
| 191 |
P-06 The roles of ghrelin and obestatin in prostate cancer
|
Amorim, L.
|
|
2008
|
18 |
S1 |
p. S28-
1 p.
|
artikel
|
| 192 |
P-13 The type 1 insulin-like growth factor receptor (IGF1R) as a therapeutic target in renal cancer
|
Wang, Y.
|
|
2008
|
18 |
S1 |
p. S30-S31
2 p.
|
artikel
|
| 193 |
P-36 Using the candidate-gene approach to investigate the predictive impact of genetic polymorphisms on response to GH replacement therapy in adults
|
Glad, C.A.M.
|
|
2008
|
18 |
S1 |
p. S37-S38
2 p.
|
artikel
|
| 194 |
P-93 Visceral fat mass, not total fat mass or body mass index, is the strongest predictor of circulating ghrelin levels in humans
|
Søndergaard, E.
|
|
2008
|
18 |
S1 |
p. S54-
1 p.
|
artikel
|
| 195 |
Scientific Program
|
|
|
2008
|
18 |
S1 |
p. vii-xvi
nvt p.
|
artikel
|
Tijdschrift beschrijving